MJ
LinkedIn

Mehdi Javanbakht

Founder and Managing Director

Greater Southampton Area · 1 connection

Optimax Access

Not on Unlinked · Imported profile. Is this you? Claim it

About

I bring nearly 20 years of experience in health economics and health technology assessment. I previously worked as an Evidence Review Group member for NICE and have led or supported more than 250 health economics and outcomes research projects, helping bring many pharmaceutical and medtech products to market. My work includes over 150 publications in peer-reviewed journals, and I am ranked among the top five most cited HTA specialists worldwide according to Google Scholar. I have advised more than 300 biopharma and medtech companies and have built over 150 economic evaluation models from scratch, including cost-effectiveness, cost-utility, cost-consequence, and budget impact models. My experience spans more than 100 therapeutic areas, including oncology, diabetes, cardiovascular diseases, and ophthalmology. I combine deep expertise in economic modeling with a strong commercial perspective. In our company we offer a wide variety of Health Economics and Outcome Research (HEOR) projects to support your business; the following are just a few examples: Economic Evidence Development • Cost-effectiveness and cost-utility models • Budget impact models • Early economic modeling and threshol

Experience

Founder and Managing DirectorOptimax Access
Aug 2017 to Jan 2026
Senior Health Economist at Newcastle UniversityNewcastle University Basic company page — company details not listed yet
Sep 2016 to Jun 2019
Senior ConsultantParexel
Jan 2016 to Dec 2016

Education

IUMS University of Medical Sciences
Doctor of Philosophy (Ph.D.) Health Economics
2010 to 2013